FindTrial
Sign In

Prognosis study of migraine in children

Prognosis of Migraine in Children: a Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043203
Enrollment
Unknown
Registered
2021-02-08
Start date
2021-02-20
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

exposure group:Nil
non exposure group:Nil

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Aged 6-18 years, male or female. (2) It met the diagnostic criteria of ICHD-3 with or without aura and chronic migraine. (3) Diagnosis of migraine by two or more professional neurologists. (4) PEDMIDAS score >=11. (5) Migraine has never been treated. (6) The purpose, significance, risks, benefits and informed consent of the study were given by patients and their family members.

Exclusion criteria

Exclusion criteria: (1) Excessive drug intake exists; (2) Autoimmune diseases; (3) Other neurological diseases and intracranial masses except migraine; (4) congenital or hereditary diseases; (5) Diabetes mellitus, bronchial asthma, cardiovascular disease, pulmonary disease; (6) Other types of primary headache and secondary headache.

Design outcomes

Primary

MeasureTime frame
Headache relief rate;CGRP;PACAP-38;VIP;SP;—

Countries

China

Contacts

Public ContactLiu Xinjie

Qilu Hospital of Shandong University

liuxinjie-ert@163.com+86 18560086300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026